Evidence map›Paper›PMID 33138315›Full record

ReviewInternational journal of molecular sciences2020

Importance of Deubiquitination in Macrophage-Mediated Viral Response and Inflammation.

Roya Rasaei, Neha Sarodaya, Kye-Seong Kim, Suresh Ramakrishna, Seok-Ho Hong

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. TheBiochemistry · 2024
    Article
  6. Article
  7. Targeting the deubiquitinaseOncology reports · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Roya RasaeiDepartment of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Korea.
Neha SarodayaGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.
Kye-Seong KimGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.
Suresh RamakrishnaGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.
Seok-Ho HongDepartment of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Korea.ORCID 0000-0002-4038-1085
Hanyang University · KRKangwon National University · KR

Funding

National Research Foundation of Korea (NRF) 2018M3A9H3022412National Research Foundation of Korea (NRF) 2019R1A2C2005453
6 · The paper itself

Abstract

Ubiquitination and deubiquitination play a fundamental role in the signaling pathways associated with innate and adaptive immune responses. Macrophages are key sentinels for the host defense, triggering antiviral and inflammatory responses against various invading pathogens. Macrophages recognize the genetic material of these pathogens as pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) through the activation of its pattern recognition receptors (PRRs), initiating the cascade of immune signaling, which leads to the production of pro- and anti-inflammatory cytokines that initiates the appropriate immune response. Macrophage-mediated immune response is highly regulated and tightly controlled by the ubiquitin system since its abnormal activation or dysregulation may result in the severe pathogenesis of numerous inflammatory and autoimmune diseases. Deubiquitinating enzymes (DUBs) play a crucial role in reversing the ubiquitination and controlling the magnitude of the immune response. During infection, pathogens manipulate the host defense system by regulating DUBs to obtain nutrients and increase proliferation. Indeed, the regulation of DUBs by small molecule inhibitors has been proposed as an excellent way to control aberrant activation of immune signaling molecules. This review is focused on the complex role of DUBs in macrophage-mediated immune response, exploring the potential use of DUBs as therapeutic targets in autoimmune and inflammatory diseases by virtue of small molecule DUB inhibitors.

Indexed as

AnimalsHumansImmunity, InnateInflammationMacrophagesReceptors, Pattern RecognitionUbiquitinUbiquitinationVirus DiseasesVirusesReceptors, Pattern RecognitionUbiquitinDUB inhibitorsE3 ligasesinnate immunitymacrophagesNOD-like receptorRIG-I-like receptorToll-like receptor

Identifiers

PMID33138315
PMCPMC7662591
OpenAlexW3095236185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.